Open Access

MicroRNA‑223 overexpression suppresses protein kinase C ε expression in human leukemia stem cell‑like KG‑1a cells

  • Authors:
    • Mallika Osiriphan
    • Charapat Insukhin
    • Songyot Anuchapreeda
    • Pinyaphat Khamphikham
    • Suwit Duangmano
  • View Affiliations

  • Published online on: May 28, 2024     https://doi.org/10.3892/mco.2024.2746
  • Article Number: 48
  • Copyright: © Osiriphan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNA‑223 (miR‑223) is dysregulated in various cancer types, including acute myeloid leukemia (AML). Despite this, there has been a lack of studies exploring the role of miR‑223 in leukemic stem cells, particularly those involved in drug resistance, a major cause of chemotherapy failure in AML. The present study aimed to elucidate the impact of miR‑223 on drug resistance in the leukemic stem‑cell line, KG‑1a. Two AML cell lines, KG‑1 and KG‑1a, differing in the proportion of CD34+CD38 cells, were assessed for doxorubicin (DOX) sensitivity using the Cell Counting Kit‑8 assay. The expression levels of miR‑223 and protein kinase C ε (PKCε) were evaluated via reverse transcription‑quantitative PCR and western blot analysis. The association between miR‑223 and its target, PKCε, was confirmed by luciferase activity assay. The effects of miR‑223 overexpression and PKCε inhibition were also evaluated in KG‑1a cells using miR‑223 mimic and small interfering (si)RNA transfection, respectively. Daunorubicin was then used to assess drug sensitivity in the siRNA‑transfected KG‑1a cells. Compared with KG‑1 cells, KG‑1a cells displayed greater resistance to DOX, and had increased PKCε levels and decreased miR‑223 expression. Overexpression of miR‑223 led to PKCε protein downregulation in KG‑1a cells, which was further confirmed by a luciferase assay demonstrating miR‑223 targeting of PKCε. However, despite these effects, miR‑223 overexpression and PKCε inhibition did not change drug sensitivity in KG‑1a cells compared with negative control cells. In summary, the present study demonstrated that miR‑223 could target and silence PKCε expression in KG‑1a cells; however, the chemoresistance of KG‑1a cells to anthracycline drugs may not be directly associated with the low expression of miR‑223.
View Figures
View References

Related Articles

Journal Cover

July-2024
Volume 21 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Osiriphan M, Insukhin C, Anuchapreeda S, Khamphikham P and Duangmano S: MicroRNA‑223 overexpression suppresses protein kinase C ε expression in human leukemia stem cell‑like KG‑1a cells. Mol Clin Oncol 21: 48, 2024.
APA
Osiriphan, M., Insukhin, C., Anuchapreeda, S., Khamphikham, P., & Duangmano, S. (2024). MicroRNA‑223 overexpression suppresses protein kinase C ε expression in human leukemia stem cell‑like KG‑1a cells. Molecular and Clinical Oncology, 21, 48. https://doi.org/10.3892/mco.2024.2746
MLA
Osiriphan, M., Insukhin, C., Anuchapreeda, S., Khamphikham, P., Duangmano, S."MicroRNA‑223 overexpression suppresses protein kinase C ε expression in human leukemia stem cell‑like KG‑1a cells". Molecular and Clinical Oncology 21.1 (2024): 48.
Chicago
Osiriphan, M., Insukhin, C., Anuchapreeda, S., Khamphikham, P., Duangmano, S."MicroRNA‑223 overexpression suppresses protein kinase C ε expression in human leukemia stem cell‑like KG‑1a cells". Molecular and Clinical Oncology 21, no. 1 (2024): 48. https://doi.org/10.3892/mco.2024.2746